Cargando…
A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21
INTRODUCTION: In accordance with social development, the proportion of advanced maternal age (AMA) increased and the cost of non-invasive prenatal testing (NIPT) decreased. OBJECTIVE: We aimed to investigate the benefits and cost-effectiveness of NIPT as primary or contingent strategies limited to t...
Autores principales: | Wang, Shuxian, Liu, Kejun, Yang, Huixia, Ma, Jingmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194099/ https://www.ncbi.nlm.nih.gov/pubmed/35712262 http://dx.doi.org/10.3389/fpubh.2022.870543 |
Ejemplares similares
-
Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
por: Neyt, Mattias, et al.
Publicado: (2014) -
Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
por: Huang, Tianhua, et al.
Publicado: (2020) -
Comparing Non-invasive Prenatal Testing With Invasive Testing for the Detection of Trisomy 21
por: Mokhtar, Rifat, et al.
Publicado: (2022) -
Birth of a child with trisomy 9 mosaicism syndrome associated with paternal isodisomy 9: case of a positive noninvasive prenatal test result unconfirmed by invasive prenatal diagnosis
por: Ma, Jingmei, et al.
Publicado: (2015) -
Clinical evaluation of the IONA test: a non‐invasive prenatal screening test for trisomies 21, 18 and 13
por: Papageorghiou, A. T., et al.
Publicado: (2015)